Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve A Webb

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Comparison of baseline characteristics, treatment and celinical outcomes of critically ill COVID-19 patients admitted in the first and second waves in AustraliaAidan J C Burrell, Ary Serpa Neto, Tessa Broadley, et al.
Trials|February 11, 2025
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trialRobert K Mahar, Anna McGlothlin, Michael Dymock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old FoeSteven Y C Tong, Jocelyn Mora, Asha C Bowen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2020
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaborationTobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2023
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolDana de Kretser, Jocelyn Mora, Max Bloomfield, et al.
ERJ Open Research|February 16, 2022
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational studyLuis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, et al.
The Lancet. Respiratory Medicine|April 18, 2025
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically illElizabeth S Munroe, Alexandra Spicer, Andrea Castellvi-Font, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19, Anthony C Gordon, Paul R Mouncey, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Comparison of baseline characteristics, treatment and celinical outcomes of critically ill COVID-19 patients admitted in the first and second waves in AustraliaAidan J C Burrell, Ary Serpa Neto, Tessa Broadley, et al.
Trials|February 11, 2025
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trialRobert K Mahar, Anna McGlothlin, Michael Dymock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old FoeSteven Y C Tong, Jocelyn Mora, Asha C Bowen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2020
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaborationTobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2023
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolDana de Kretser, Jocelyn Mora, Max Bloomfield, et al.
ERJ Open Research|February 16, 2022
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational studyLuis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, et al.
The Lancet. Respiratory Medicine|April 18, 2025
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically illElizabeth S Munroe, Alexandra Spicer, Andrea Castellvi-Font, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19, Anthony C Gordon, Paul R Mouncey, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
Pageof 3